John Hamer
InvestorManaging Partner, DCVC Bio at DCVC Bio · Managing Partner, DCVC Bio at DCVC (Data Collective) · Board director at Avicenna Biosciences · Board director at Umoja Biopharma, Inc. · Board director at Pivot Bio
San Francisco, California
Writes $5M – $25M checks · typically $15M
About
Co-founder and Managing Partner of DCVC Bio, focused on computational biology and life sciences investments.
Contact· self-published, not guessed
Likely emails· guessed from name + firm domain, not firm-published
- j•••@dcvc.comreveal100% confident
- j•••@dcvc.comreveal90% confident
- j•••@dcvc.comreveal80% confident
Invests in
BiotechClimate TechData & InfrastructureDeep TechHardwareHealthtech
Beyond investing
- Education
- Studied at UC Berkeley (Electrical Engineering and Computer Science)
From published sources — common ground for a warm intro.
Board director at Avicenna Biosciences
Intro paths
In turn, John can intro founders to Avicenna Biosciences's investors below.
Avicenna Biosciences's investors · 1
Board director at Umoja Biopharma, Inc.
Intro paths
In turn, John can intro founders to Umoja Biopharma, Inc.'s investors below.
Umoja Biopharma, Inc.'s investors · 7
Co-founders at Umoja Biopharma, Inc.
Board director at Pivot Bio
Intro paths
In turn, John can intro founders to Pivot Bio's investors below.
Pivot Bio's investors · 13
Co-founders at Pivot Bio


Experience
- DCVC BioManaging Partnercurrent2018 — present500 2nd Street San Francisco CA
- University of California, Davis Graduate School of ManagementInvited Lecturercurrent2009 — present
- CIATBoard of Trustee2012 — 2018Cali, Colombia
- MonsantoMonsanto Growth Ventures2012 — 2018San Francisco Bay Area
- Chromatin, Inc.Chairperson2008 — 2012Greater Chicago Area
- Burrill & CompanyManaging Director2003 — 2011
- Arete TherapeuticsCEO2003 — 2006
- Paradigm Genetics (Icoria)CSO, CEO, VP Business Development1998 — 2003
- Purdue UniversityProfessor of Biological Sciences1988 — 2000
- Academic Press Inc.Editor-In-Chief, Fungal Genetics and Biology1993 — 1999
- DuPontVisiting Scientist1987 — 1989
Skills & more
+12 more
BiomarkersBiopharmaceuticalsBusiness DevelopmentChemistryClinical DevelopmentClinical TrialsCommercializationCorporate DevelopmentStrategyDrug DiscoveryEmerging MarketsEntrepreneurshipFrom John's professional profile.
Investments
Investor
AtomwiseBlue River Technologies
Per curated public sources.
Colleagues at DCVC Bio
Frequently asked questions
- Who is John Hamer?
- Co-founder and Managing Partner of DCVC Bio, focused on computational biology and life sciences investments.
- Where does John Hamer work?
- John Hamer is Managing Partner, DCVC Bio at DCVC Bio and Board director at Avicenna Biosciences and Board director at Umoja Biopharma, Inc. and Board director at Pivot Bio.
- What does John Hamer invest in?
- John Hamer invests in Biotech, Climate Tech, Data & Infrastructure, Deep Tech, Hardware, Healthtech.
- What check size does John Hamer write?
- John Hamer typically writes checks of $5M – $25M.
- What companies has John Hamer invested in?
- Investments tracked here include Atomwise, Blue River Technologies.
- Where did John Hamer go to school?
- John Hamer studied at University of California, Davis (Ph.D, Microbiology); University of Windsor (M.Sc., Biological Sciences); University of Windsor (B.Sc., Biology).
Same school
Also attended University of California, Davis154
+ 148 more
Also attended University of Windsor27
+ 21 more
Shared employers
Also worked at University of California, Davis Graduate School of Management3
Also worked at CIAT1
Also worked at Monsanto34
+ 28 more


































